BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/27/2020 9:27:48 AM | Browse: 943 | Download: 1765
 |
Received |
|
2020-06-25 21:10 |
|
Peer-Review Started |
|
2020-06-25 21:11 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-07-28 21:31 |
|
Revised |
|
2020-08-26 10:03 |
|
Second Decision |
|
2020-11-04 10:09 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-11-09 01:14 |
|
Articles in Press |
|
2020-11-09 01:14 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-11-25 11:07 |
|
Publish the Manuscript Online |
|
2020-11-27 09:27 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Amera Elzubeir and Syed Munawer Alam |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Syed Munawer Alam, FRCP, MBBS, Doctor, Doctor, Department of Gastroenterology, Norfolk and Norwich University Hospital, Colney Lane Norwich Norfolk, Norwich NR46AY, Norfolk, United Kingdom. syed.alam@nnuh.nhs.uk |
| Key Words |
Hepatic encephalopathy; Cirrhosis; Rifaxamin; Portal hypertension; Acute on chronic liver failure; Prognosis |
| Core Tip |
This letter to editor serves to add to the ongoing conversation regarding hepatic encephalopathy (HE) and its prognostic significance. The major highlight of this letter is to stress the importance of recognizing other prognostically significant variables such as sarcopenia and active Hepatitis C, which may adversely impact the severity and outcomes of HE. Furthermore it serves to actively encourage future studies in this area. |
| Publish Date |
2020-11-27 09:27 |
| Citation |
Elzubeir A, Alam SM. Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’. World J Gastroenterol 2020; 26(44): 7085-7087 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i44/7085.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i44.7085 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
